Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu -- Ignore unavailable to you. Want to Upgrade?

To: Think4Yourself who wrote (3753)	5/2/2006 3:49:46 AM
From: Maurice Winn	Respond to of 4232

JohnQ, since the virus has been rampant in birds, the virus will be losing it's murderous ability in them, in the same way it would do once it has been through humans. When enough wild birds are immune, H5N1 will be reduced to a pool, low-level infection and might even lose out completely to competing infections. Hosts can't carry unlimited supplies of viruses and very fatal ones are soon filtered out of the hosts. If birds become immune before humans are infected, the probability of crossover to humans will reduced as the probability of a human with flu getting infected at the same time as a bird passes on H5N1 reduces. If by next winter, H5N1 isn't rampaging in humans, I'd say it's in trouble. Vaccines will be closer to ready in the event that the virus does succeed in humanizing. It is now May so the bug has definitely missed out this northern winter. Mqurice